CD163 and neoplasm: Recent reports demonstrated HL patients with the highest M2 TAM count, measured using CD163 or CD68/CD163 as M2 polarization markers, had a significantly reduced disease-free survival (DFS), PFS and OS, further confirming M2 TAM could support tumor progression and immune escape [122,123,128,129].